icatibant acetate
icatibant acetate is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Firazyr. Available dosage form: injection, solution.
Drug Details
- Generic Name
- icatibant acetate
- Brand Names
- Firazyr
- Application Number
- NDA022150
- Sponsor
- Takeda Pharmaceuticals America, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- ICATIBANT ACETATE
Indications and Usage
1 INDICATIONS AND USAGE FIRAZYR ® (icatibant) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. FIRAZYR is a bradykinin B2 receptor antagonist indicated for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. ( 1 )